Cited by 19Iron Metabolism and DisordersErythropoietin and Anemia TreatmentHemoglobin structure and function

Divergent effects of α1-antitrypsin on the regulation of iron metabolism in human erythroleukaemic (K562) and myelomonocytic (THP-1) cells

Open access
WEISS, Günter, GRAZIADEI, Ivo, URBANEK, Martina, GRÜNEWALD, Kurt, VOGEL, Wolfgang·1996·Biochemical Journal

Abstract

The acute-phase protein alpha 1-antitrypsin (alpha 1-AT) has been shown to inhibit the binding of transferrin to its cell-surface receptor. Here we demonstrate that in human erythroleukaemic cells (K562) alpha 1-AT enhances the binding affinity of iron-regulatory protein (IRP), the central regulator of cellular iron metabolism, to iron-responsive elements. Activation of IRP by alpha 1-AT is associated with a marked increase in transferrin receptor (trf-rec) mRNA levels in K562 and enhanced cell-surface expression of transferrin-binding sites, whereas ferritin production is decreased, although ferritin mRNA levels remain unchanged. In agreement with the well-established mechanism of cellular iron regulation, alpha 1-AT seems to modulate trf-rec and ferritin expression primarily post-transcriptionally/translationally by influencing IRP activity. In contrast, alpha 1-AT produces only minor changes in IRP activity, and subsequently in trf-rec expression and ferritin synthesis in THP-1 cells. Moreover the effects of alpha 1-AT on iron homeostasis in K562 cannot be overcome by the addition of iron salts, whereas concomitant treatment of THP-1 with iron and alpha 1-AT results in the same metabolic changes as the addition of iron alone. Because alpha 1-AT blocks transferrin binding on K562 as well as on THP-1 cells, it is suggested, on the basis of the results presented here, (1) that erythroid and monocytic cells might differ in their dependence on transferrin-mediated iron supply and (2) that THP-1 might be able to acquire iron by a transferrin-independent iron uptake system. alpha 1-AT might therefore be involved in the diversion of iron traffic between various cellular compartments under inflammatory conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj3190897

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A1AT can be considered part of an amplification loop that reinforces the hypoferremia of the acute-phase response.

    “Therefore, A1AT can be considered as part of an amplification loop that reinforces this hypoferremia of the APR (Weiss et al., 1996).”

    From Iron in infection and immunity (2020) · cites this paper as Weiss et al., 1996

    The Discussion (page unavailable) suggests that α1-antitrypsin, an acute-phase protein, might divert iron traffic during inflammation by reducing iron uptake into erythroid cells while sparing uptake by monocytes/macrophages. That supports a possible role in inflammatory iron redistribution, but the paper does not establish an amplification loop or show that α1-antitrypsin reinforces hypoferremia. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 42 · Cited by 19

Research works printed but not linked: 8

  1. Perlmutter, D. H., Glover, G. I., Rivetna, M., Schasteen, C. S. and Fallon, R. J. (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 3753-3757 Received 23 April 1996/8 July 1996 ; accepted 15 July 1996
  2. Leibold, E. A. and Munro, H. N. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 2171-2175
  3. Aziz, N. and Munro, H. N. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 8478-8482
  4. Hentze, M. W., Rouault, T. A., Caughman, S. W., Dancis, A., Harford, J. B. and Klausner, R. D. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 6730-6734
  5. van Renswoude, J., Bridges, K. R., Harford, J. B. and Klausner, R. D. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 6186-6190
  6. Dautry-Versat, A., Ciechanover, A. and Lodish, H. F. (1983) Proc. Natl. Acad. Sci.
  7. Klausner, R. D., Ashwell, G., Van Renswoude, J., Harford, J. B. and Bridges, K. R. (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 2263-2266
  8. Brock, J. H. (1994) in Iron Metabolism in Health and Disease (Brock, J. H., Halliday, J. W., Pippard, M. J. and Powell, L. W., eds.), pp. 353-389, Saunders, Philadelphia, PA 41

Authors
WEISS, G., GRAZIADEI, I., URBANEK, M., GRÜNEWALD, K., & VOGEL, W.
Affiliations
Innsbruck Medical University (AT)
Venue
Biochemical Journal
Published
1996-11-01
Volume
319
Issue
3
Pages
897-902
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W47729270
Cited by
19
References
42
Citations by year
2020: 1 · 2018: 1 · 2013: 2 · 2012: 1
FWCI
0.87
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hemoglobin structure and function
Keywords
alpha-1-antitrypsin, iron metabolism, iron regulatory proteins, transferrin receptor, transferrin binding, ferritin, K562 cells, THP-1 cells, erythroid cells, monocytic cells, iron-responsive element, acute phase proteins, iron homeostasis, inflammation
MeSH terms
alpha 1-Antitrypsin, Cell Line, Deferoxamine, Leukemia, Erythroblastic, Acute, Ferritins, Humans, Iron, Iron-Sulfur Proteins, Kinetics, Receptors, Transferrin, RNA, Messenger, Transcription, Genetic, Tumor Cells, Cultured, Leukemia, Myelomonocytic, Acute, RNA-Binding Proteins, Iron-Regulatory Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review